Ranexa (ranolazine extended-release tablets) for the treatment of chronic angina does not depend upon reductions in heart rate or blood pressure http://www.ranexa.com/wir_indications.html
  spacer  
spacer
 
right header
What Is Ranexa?
 

Indication

title right border
spacer spacer spacer
left border
  • Ranexa is indicated for the treatment of chronic angina
  • Because Ranexa prolongs the QT interval, it should be reserved for patients who have not achieved an adequate response with other antianginal drugs
  • Ranexa should be used in combination with amlodipine, beta-blockers, or nitrates
  • The effect on angina rate or exercise tolerance appeared to be smaller in women than men
spacer
spacer spacer spacer
left border
Learn more about Clinical Studies link right arrow
Read Patient Profiles link right arrow
See full Prescribing Information link right arrow
Back to top
spacer
 
 
yellow footer
CVT Logo This website is intended for
US Healthcare Professionals only